TETRAPHASE PHARMACEUTICALS INC: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2019)
- $7.4M
- Net Income/Loss (FY2019)
- -$70.1M
- Total Assets (FY2019)
- $36.4M
- Total Equity (FY2019)
- $23.2M
- Cash Flows from Operating Activities (FY2019)
- -$63.7M
Source: TETRAPHASE PHARMACEUTICALS INC 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
